"This letter concerns your firm's distribution of products that violate the Federal Food, Drug, and Cosmetic Act. The FDA purchased on your website products that are labeled as energy enhancing supplements or food, but laboratory analyses confirmed that they contained undeclared and potentially harmful active pharmaceutical ingredients," the agency said.